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Abstract Introduction: Rheumatic diseases are considered public health problems affecting millions of people 
worldwide resulting in high and rising health-care costs. In this work, Fourier Transform Infrared spectroscopy 
associated to Partial Least Square regression (PLS) analysis was used to diagnose rheumatoid arthritis (RA) 
from human serum. Methods: The sera of 94 individuals were collected, which included 47 from rheumatic 
patients and 47 from healthy individuals. The results from PLS analysis were compared to standard clinical 
trials such as anti-citrullinated peptide antibodies, C- Reactive protein, and Rheumatoid factor. Results: For 
clinical diagnosis, the anti-citrullinated peptide antibodies of second generation proved to be the most specific 
to diagnosis rheumatoid arthritis even after long periods of drug therapy. Conclusions: The qualitative PLS 
analysis has shown higher values of IgM of RA group, but the difference was very small. The RA patients 
were under medication, which interfered with the IgM concentration.
Keywords FTIR spectroscopy, Human serum, Rheumatoid arthritis, Partial Least Square.
Introduction
Rheumatic diseases are considered public health 
problems affecting millions of people worldwide 
resulting in high and rising health-care costs 
(Cheng et al., 2010; Desai et al., 2010; Waljee and 
Chung, 2011). For example, in 2003, the United 
States of America spent a total of 128 billion US$ 
on rheumatoid arthritis (RA), which is just one type 
of rheumatic disease (Birch and Bhattacharya, 2010; 
Centers…, 2011). Of this sum, 3.6 billion US$ were 
spent on drug therapies (Waljee and Chung, 2011) and 
about US$ 14,000 on cardiovascular disease associated 
with an increased prevalence of coronary artery disease 
present in RA (Desai et al., 2010). In the period from 
2007 to 2009, US statistical data indicate an increase 
of approximately a million of new RA cases per year 
(Cheng et al., 2010).
RA affects approximately 0.5-1% of the world 
population (Hambright et al., 2011; Martínez et al., 
2011), being more common in women than in men, and 
in ages between 40 and 60 years (Ebringer et al., 2010). 
RA is the most common systemic autoimmune disease 
in the world (Haro et al., 2011), and it causes functional 
disability and premature death. Approximately 70% of 
patients have irreversible joint destruction and 80% of 
active young adults in the labor market are affected by 
stiffness and devastating pain (Filipovic et al., 2011). 
This situation generates a big loss of daily activities 
and vocational productivity resulting in significant 
reduction in quality of life (Waljee and Chung, 2011).
Regarding the etiology of the disease, cigarette 
smoking is described as a possible risk factor for the 
onset or worsening of RA. Smoking is associated 
with a worse prognosis of the disease (Karlson and 
Deane, 2012; Okamoto et al., 2011; Ruiz-Esquide 
and Sanmartí, 2012). In contrast, little has been said 
about better eating habits or the benefits of physical 
activity in this population. The implementation of 
programs of physical training and nutrition education 
could provide greater independence and quality of life 
to RA patients (Külkamp et al., 2009; Plasqui, 2008). 
Therefore, it is necessary to explore theses parameters 
within a public health system.
The clinical approach to diagnosis RA is based 
on the standard procedure established by the ACR 
(American College of Rheumatology) in 1987. 
However, this has been widely criticized due to 
the lack of sensitivity for early detection of the 
disease. Therefore, the ACR and European League 
Against Rheumatism (EULAR) has developed a 
new set of criteria to classify RA based on new 
laboratory parameters such as anti-citrullinated peptide 
antibodies (anti-ACPA), C- Reactive protein (CRP), 
and Rheumatoid factor (RF). The new set of criteria 
aims to identify early RA patients in order to institute 
early drug therapy, thereby reducing the functional 
disability and articular lesions (Aletaha et al., 2010). 
High concentrations of CRP, RF, and ACPA in serum 
are associated with unfavorable outcomes, including 
persistent disease, joint destruction, and functional 
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disability. The studies correlating clinical trials 
(symptoms and signs) with radiographic exams have 
shown that patients with low titre and/or negative 
RF/ACPA have a better prognosis (Malaviya et al., 
2009). This RF in RA patients may have different 
classes of gammaglobulins such as IgM, IgG, or IgA. 
Nevertheless, classes of IgM and IgG-RF are more 
correlated with the disease and are abundantly produced 
by plasma cells in synovial tissue (Duquerroy et al., 
2007; Firestein et al., 2009).
The ACR and EULAR have been using these 
biomarkers as part of the classification criteria for 
early diagnosis, thereby ensuring the opportunity 
of early treatment and prevention of irreversible 
deformities. However, there are some problems in 
the tests due to the mismatch between specificity 
and sensitivity. The ACR uses RF as a biomarker 
that can be detected in 70-80% of patients with RA, 
but it can also be found in other rheumatic diseases. 
Therefore, it is a test for a non-specific biomarker, 
which is also present in infections and about 5-10% 
of healthy individuals (Birch and Bhattacharya, 2010; 
Ryu et al., 2011). The CRP test is based on the increase 
in serum C-reactive protein, which is synthesized in 
great amounts immediately after any tissue damage. 
Thus, CRP test is not specific and it is elevated in all 
inflammatory and infectious processes as well as in 
the RA. Elevated plasma levels are detected within 4 
to 6 hours after injury and peak levels are found after 
24 to 72 hours (Otterness, 1994). ACPA antibody is 
considered the most specific marker for RA, but the 
sensitivity is not greater than 70% (Cai et al., 2011).
Another possibility for early diagnosis is the 
antiperinuclear factor (APF) antibody, which was 
originally described by Nienhius et al. (1964) by 
indirect immunofluorescence technique. APF is an 
autoantibody that reacts against antigens present in 
keratohyalin granules of human oral mucosa. APF 
is distributed predominantly around the nucleus of 
keratinocytes (Vander Cruyssen et al., 2005). High 
levels of APF are considered specific for RA and 
the molecular characterization of these antigens 
resulted in the discovery of citrullinated peptides. 
From this characterization, enzyme immunoassays 
for antibodies to citrullinated peptide are produced 
commercially (ACPA) by ELISA method. These new 
laboratory tests combined with imaging methods such 
as ultrasound and magnetic resonance imaging of 
affected joints have largely contributed to the early 
diagnosis, which is very important to improve patient´s 
quality of life (Hsin-Hua et al., 2010; Narváez et al., 
2008; Nienhius et al., 1964; Østergaard et al., 2008). 
However, most immunochemical assays for anti-CCP 
(ELISA) and APF have limited utility for routine 
clinical practice due to the complexity of procedures 
and the need for qualified technicians (Liao et al., 
2011; Santos et al., 1997).
The several medications administrated to RA 
patients lead to changes in the serum composition. 
The persistent and progressive inflammation of the 
synovial tissue causes joint destruction, affecting 
mainly the hands (Waljee and Chung, 2011). To try 
to combat or reduce the loss caused by this disease, 
the medical community makes use of nonsteroidal 
anti-inflammatory drugs (NSAID) and low-dose 
glucocorticoids, associated with modifying anti-
rheumatic drugs (DMARDs) (Elefant et al., 2010; 
Mouterde et al., 2011).
Nevertheless, the negative sides effects of steroids 
are a limiting factor, and the dose must be the lowest 
possible to achieve therapeutic benefit. NSAIDs should 
not be used alone, as they do not change the course 
of the disease. Most RA treatment includes NSAIDs 
for pain control, glucocorticoids and the initiation of 
a DMARDs (Birch and Bhattacharya, 2010).
Fourier Transform Infrared Spectroscopy (FTIR) 
analysis has the potential to provide rapid results and 
may be adapted for a clinical test with high values 
of sensitivity and specificity (Carvalho et al., 2011; 
Naumann, 2008; Raniero et al., 2011). In this article, 
FTIR (Petibois et al., 1999; Sankari et al., 2010) was 
used as tool to investigate sera of RA and normal (N) 
individuals, using Partial Least Square (PLS) regression 
analysis (Muñoz de la Peña et al., 2007). The results 
were compared to different laboratory techniques 
such as CRP, RF, anti-CCP, APF. In addition, we 
also analyzed possible interference of medication 
and food in the two evaluated groups.
Methods
This work was approved by the Ethics Committee of 
the Institute of Research and Development (IP&D), 
University of Vale do Paraíba (UniVap) following the 
Guidelines and Norms Regulating Research involving 
human, H119CEP/2010.
Selection of the volunteers was done through a 
questionnaire with information about diet, medications, 
lifestyle, and the most recent meal. The parameters 
of exclusion and inclusion were pre-adjusted for 
both groups. The healthy group was comprised 
only of women from 30 to 60 years old, due to the 
predominance of the disease in women, and the 
disease group was formed by women with confirmed 
RA diagnosis, according to criteria established by 
the ACR 2010.
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Blood samples
The 94 blood samples were collected at UNIFESP 
(Federal University of São Paulo) and the Department 
of Hemotherapy and Hematology of São José dos 
Campos, in agreement with requirements and 
recommendations of Brazilian Society of Clinical 
Pathology (SBPC)/Laboratory of Medicine for venous 
blood (Andriolo et al., 2009). Of the blood samples, 47 
were from patients with RA (chronic phase and with 
long-term drug therapy) and 47 from healthy subjects. 
The procedure adopted for collecting venous blood 
was as follows: 1) Collection of whole blood in the 
antecubital region of the right arm using venipuncture; 
2) Storage in sterile tube, gel-barrier vacuum (BD 
Vacutainer SST Advance Tube, 5 mL, Gold) for 30 
min at room temperature; 3) Centrifugation at 4000 g 
for 6 min; and 4) Separation of serum, that was 
stored in polypropilene tubes and placed in sealed 
polypropylene styrene boxes for transportation and 
storage of the material at –23 °C.
Clinical analysis
The analysis of rheumatoid factor and C-reactive 
protein were started immediately after the blood 
collection. RF and CRP were evaluated by latex 
agglutination test (Wama Diagnóstica®), based on 
indirect agglutination of latex particles coated with 
human IgG and monoclonal anti-CRP antibody, 
respectively.
The sensitivity of the tests corresponded to 8 Ul/
ml for RF and 6 mg/liter for CRP. The tests for APF 
(antiperinuclear factor) and ACPA 2nd generation 
were performed at Rheumatology Division at Escola 
Paulista de Medicina. The determination of ACPA2 
was done using Quanta LiteTM CCP2 IgG Elisa, kit 
(INOVA Diagnostics, Inc., San Diego, CA, USA), 
according to the manufacturer’s instructions, which 
set the cut off at 20 U/ml. ACPA titers between 20 and 
39 U/ml were considered weakly positive, between 40 
and 59 U/ml as moderately positive, and ≥ 60U/ml as 
strongly positive. APF was determined as described 
by Hoet et al. (1991) with slight modifications as 
established in Brazil by Santos et al. (1997).
Medications and diet
The drugs used in the RA group were non-
biological and biological. The non-biological 
DMARDs were Methotrexate (MTX), leflunomide, 
hydroxychloroquine, sulfazalasine, and cyclosporine. 
The biological medications are divided in subgroup 
such as: 1) TNF blockers: Adalimumab, etanercept, and 
infliximab; 2) Depletors B lymphocytes: Rituximab; 
3) Modulators of co-stimulation: Abatacept. For pain 
control and inflammation of the joints, nonsteroidal 
anti-inflammatory drugs (NSAIDs) were used alone 
or combined with low doses of glucocorticoids (up to 
15 mg of prednisone) (Bértolo et al., 2007). In the N 
group, the only drugs allowed were anti-hypertensives 
and oral hormone replacement therapy.
The information about the most recent meal from 
RA and N groups was evaluated through the TACO 
table (Brazilian Table of Food Composition). The 
TACO Table contains the information about the 
composition of Brazilian foods (Universidade…, 
2011). This table was prepared by the Center for 
Studies and Research in Food (NEPA- UNICAMP) 
and approved by the National Agency for Sanitary 
Vigilance.
Fourier Transform Infrared Spectroscopy
A thin serum film was made with a drop (1 µl) of the 
samples deposited on calcium fluoride (CaF2) window 
and dried using an Eppendorf Concentrator 5301. The 
spectra of the samples were recorded in the range of 
4000-900 cm–1, with 64 scans and a spectral resolution 
of 4 cm–1, using a FTIR spectrometer (Perkin-Elmer, 
Spotlight 400). The spectra were collected using the 
single detector mode of the microscope. To analyze 
spectral data, the spectrum Image, Spotlight 400 
Software, version 3.6.2 was used.
Statistical analysis
The values obtained through the questionnaire were 
evaluated, consolidated, and tabulated using a binomial 
distribution by the statistic software IBM SPSS® 19.0.
PLS analysis was constructed from serum proteins 
known as bovine serum albumin (BSA) and human 
immunoglobulin M class (IgM) antibodies, which 
were purchased from Sigma Aldrich. The human 
and bovine albumins have very similar primary 
structures, both being widely used in biochemical 
and biophysical studies (Gelamo and Tabak, 2000). 
From the spectroscopic view point, an important 
difference between these proteins is that the albumin 
has only one tryptophan residue (Trp214) and bovine 
albumin possesses two tryptophan residues (Trp134 
and Trp212) (Cheng, 2012).
Results
Figure 1 shows the sensitivity and specificity values 
of CRP, RF, APF, and ACPA analysis for N and RA 
groups. The RF and CRP analysis were performed 
for both groups. However, the APF and ACPA were 
done only for RA group due to high specificity of 
RA diagnosis (Lutteri et al., 2007; Santos et al., 
1997; Swart et al., 2012). All tests have shown high 
values of specificity, but there are many differences 
on sensitivity, which will be remarked upon later in 
this text.
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Risk factors, diet, and medications
Table 1 shows the prevalence of smoking, physical 
activity and nutrition of N and RA groups. The values 
p ≤ 0.05 indicate significant differences between the 
variables, a fact apparent in both N and RA groups. By 
identifying such similarities, it is possible to correlate 
the variations found in both groups. Initially it was 
found that the role of smoking in the inflammatory 
process is still the subject of study.
The positive reactions of RF and ACPA antibodies 
in RA patients were compared in smokers, ex-smokers, 
and non-smokers, with 24 non-smokers and 23 smokers 
or ex-smokers. The frequency of positive ACPA assay 
was similar in both RA subgroups (66.7% and 78.3% 
with a difference of 11.6% respectively). A positive 
RF assay was 4.2% for non-smokers and 13% for 
smokers or ex-smokers, with a difference of 8.8%.
With respect to physical activity, both groups 
had a sedentary lifestyle with p < 0.05, showing that 
most of the population studied did not practice regular 
physical activity.
The statistic results of food taken in the most recent 
meal found a higher cholesterol level for rheumatic 
patients compared to normal individuals. However, 
with respect to other variables both groups showed 
similar variations, with p < 0.05, demonstrating a 
percentage intra-group fairly heterogeneous.
Table 2 shows the most used medications for 
rheumatic and healthy individuals in this study. 
Methotrexate, leflunomide, and prednisone are among 
the most widely prescribed rheumatics drugs due to 
their clinical efficacy and low toxicity. In both groups, 
the use of antihypertensive drugs is present.
Partial Least Square analysis
Figure 2 shows the frequency in serum concentration 
of IgM and BSA of the rheumatic and normal groups. 
The normal individuals have values ranging from 2.4 to 
4.0, while rheumatic individuals vary from 2.6 to 4.2.
Discussion
 Our study suggests that even after long-term drug 
therapy (9 ± 7.9 years), the biomarker ACPA is 
still present in the circulatory system of rheumatic 
individuals. This autoantibody showed high specificity 
and less sensitivity (see Figure 1). Similarly, Swart et al. 
(2012) evaluated rheumatic patients (disease duration 
8.5 years) using the same ACPA 2nd generation kit, 
and obtained the following values of sensitivity/
specificity (77.3/98.1%). Van Venrooij et al. (2006) 
report that the sensitivity of the test ranges between 
60% (early RA) and 77% (established RA). The ACPA 
positive patients usually remain positive despite 
treatment, and slight declines or even an increase 
the titers of ACPA may occur (Niewold, 2007). 
These differences make it impossible to confirm 
the effectiveness of anti-rheumatic medications on 
stability/reduction of this autoantibody. The use of 
this biomarker in the monitoring of rheumatic patients 
during treatment or their relation to disease activity 
is still controversial and unexplored. Currently, it is 
necessary to standardize evaluative concepts, such as: 
1) monitoring of biomarkers before and during the 
course of the disease; 2) detailing of the medications; 
and 3) evaluation of clinical and functional signs. 
Although the ACPA is more specific for RA, it does 
not exclude the diagnosis of other autoimmune diseases 
Figure 1. Sensitivity and specificity values of laboratory tests.
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(psoriatic arthritis, systemic lupus, and Sjögren´s 
syndrome) (Vander Cruyssen, 2005).
In the present study, the high specificity and 
reduced sensitivity found in the RF analysis may be 
due to the low sensitivity of our method by indirect 
agglutination. Swart et al. (2012) and Liao et al. (2011) 
observed a higher sensitivity and lower specificity of 
RF (65.2/89.6% and 67.4/84.3%) by turbidimetry and 
nephelometry analysis, respectively. This variation 
can be attributed to the choice of technique used. 
Nevertheless, the specificity and sensitivity of RF 
have been improved by the development of enzyme-
linked immunosorbent assays (ELISA), which permit 
the detection and quantitative measurement of RF of 
various IgG-, IgA-, and IgM-RF class immunoglobulins 
(Vallbracht and Helmke, 2005). The more specific 
techniques for testing these classes by ELISA are 
nephelometry and turbidimetry with 90% sensitivity 
(Firestein et al., 2009). However, discrepancies in 
the values of RF measurements are widely found 
(Van der Linden et al., 2011). Recent data suggest 
that IgM-RF as well as other RFs play an important 
role in the pathogenesis of rheumatoid arthritis, thus 
Table 1. Percentage values (%) of smokers, individuals who practice physical activity (at least 3 times per week), and food intake before the 
venous blood test in N and RA groups. Source: Universidade Estadual de Campinas (2011) (Anvisa/Ministry of Health). 
Variables
N (%) RA (%)
Yes No p Yes No p
Smokers 19 81 *0.000 15 85 *0.000
Physical activity 32 68 *0.019 28 72 *0.03
Fasting 0 100 *0.000 13 87 *0.000
Lipids 70 30 *0.008 68 32 *0.019
Cholesterol 15 85 *0.000 64 36 0.079
Saturated 74 26 *0.001 68 32 *0.019
Monounsaturated 74 26 *0.001 68 32 *0.019
Polyunsaturated 74 26 *0.001 68 32 *0.019
Carbohydrate 83 17 *0.000 87 13 *0.000
Proteins 79 21 *0.000 70 30 *0.008
 *p < 0.05 in relation to the intra-group differences.
Figure 2. Differences of IgM/Albumin ratio for RA and N groups by PLS.
Table 2. Medications commonly used by the rheumatism and 
normal groups.
Medications Yes Not p
RA group
Methotrexate 64 36 0.079
Prednisone 55 45 0.560
Leflunomide 26 74 *0.001
Chloroquine 13 87 *0.000
Adalimumab 11 89 *0.000
Sulfasalazine 09 91 *0.000
Hydroxychloroquine 06 94 *0.000
Etanercept 06 94 *0.000
Infliximab 04 96 *0.000
Rituximab 02 98 *0.000
Abatacept 02 98 *0.000
Cyclosporine 02 98 *0.000
Antihypertensives 47 53 0.771
NSAIDs  19  81  *0.000
N group
Hormones (T4) 08 92 *0.000
Contraceptive 21 79 *0.000
Antihypertensive 06 94 *0.000
*p< 0.05 in relation to the intra-group differences.
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being one of the more frequently used RFs in research 
(Ahmed et al., 2010; Zavala-Cerna et al., 2008). 
ACPA has a specificity of (91-98%), which is more 
specific than RF (Romic et al., 2009; Ryu et al., 2011). 
The ACPA and RF biomarkers are distinct, but are 
complementary tools to investigate RA.
The CRP and RF values are similar to those 
described in the literature by indirect agglutination 
(Carvalho et al., 2011). Our findings show a decrease in 
sensitivity values of CRP, which suggests a stabilization 
of disease activity and joint destruction. In general, 
improvement in CRP levels indicates that a drug 
has produced a beneficial effect and may be useful 
for monitoring effects of therapy (Otterness, 1994).
The APF analysis had a lower sensitivity compared 
to with CRP tests. Cordonnier et al. (1996) investigated 
the APF marker in individuals with RA for a period 
of 24 months, obtaining a sensitivity/specificity 
of 28.6/95%. Approximately 50% of patients with 
RA early-onset and FR-negative (< 2 years) have 
APF positive and sensitivity/specificity of 59/95% 
(Santos et al., 1997). The results shown are consistent 
with the current literature. Other studies correlating 
this biomarker with advanced RA could not be found.
Table 1 illustrates some risk factors such as 
smoking and physical inactivity. Our study shows 
an involvement of smoking in the aggravation of 
the positivity of RF and ACPA rheumatic markers. 
However, the role of smoking in the inflammatory 
process is still unknown. Goeldner et al. (2011) 
verified that smoking influences the frequency of 
ACPA2 positivity, increasing by 2.7 times the risk 
for high titer ACPA. In addition, they observed that 
the females exposed to tobacco had this rate 7.7 
times increased compared to men. Alsalahy et al. 
(2010) also claims that the levels of ACPA and RF 
are higher in smokers. Arnson et al. (2010) described 
that cigarette smoking affects the immune system in 
diverse ways, both increasing inflammatory allergic 
and autoimmune reactions, and decreasing systemic 
activity against infections. Smokers with RA have a 
disease characterized by a greater proportion of auto-
antibody positivity. This emphasizes the importance 
of prevention/eradication of its use in order to avoid 
respiratory complications and autoimmune conditions.
The N and RA groups presented similar 
characteristics in relation to physical activity, being 
composed of large number of sedentary individuals. 
Plasqui (2008) describes that exercise contributes to the 
improvement of aerobic conditioning and stretching. 
Consequently, the quality of life and activities of 
daily living are improved. Furthermore, exercise 
does not cause deleterious effects on the health of 
the rheumatoid patient, i.e., it does not increase pain 
conditions, disease progression, or joint damage. 
Benhamou et al. (2007) warns that prolonged bed 
rest in patients with RA may lead to deconditioning 
and functional decline. In contrast, more detailed 
investigations about the role of physical activity on 
the progression of RA should be conducted.
In relation to eating, an important challenge for 
the present methodology is sample standardization, 
because serum carries several relevant components, 
such as protein, lipids, vitamins, carbohydrates, etc. 
The concentrations of each of these are not constant, 
but depend on the diet content, interval between 
meals and sample collection, medications, hormone 
cycles, genetic factors, metabolic activity, etc. Among 
this enormous variation, the main objective is to 
identify biomarkers that could reliable correlate to 
relevant clinical parameters despite the influence of 
extraneous factors. Many experts describe the high 
potential of the infrared technique to diagnose different 
diseases from serum, but the influences of the above 
mentioned extraneous factors in spectral interpretation 
is still largely unknown (Déléris and Petibois, 2003; 
Petibois et al., 2001; Staib et al., 2001).
The current study presents the most used 
medications for treating rheumatism, especially 
methotrexate (64%) and prednisone (55%). 
Alarcón et al. (1990) reports that MTX causes a 
suppression of rheumatoid factors class A and M 
immunoglobulin in human serum, which leads to a 
decrease of these autoantibodies in all patients who 
used the drug. Bathon et al. (2000) describes that 
MTX reduced disease activity, and this correlated 
with the absence of progressive radiographic evidence. 
Lipsky et al. (2000) also reports that MTX associated 
with infliximab significantly improved clinical benefit 
and radiographic progression stops. Klaasen et al. 
(2011) demonstrates that therapy with infliximab 
reduces the levels of RF and ACPA antibodies after 
16 weeks of treatment, which was also confirmed in 
our results for patients with lowest treatment time, 
13 months. Other drugs such as adalimumab and 
etanercept, also known as biologic DMARDs or 
TNF blockers, and non-biological DMARDs also 
showed similar effects, with reduced levels of RF 
and ACPA throughout drug treatment (Atzeni et al., 
2006; Fries et al., 1996). Thus, the lowest values of 
autoantibodies were evidenced by efficient treatment 
through stabilization of immune activities. However, 
a long period of autoantibodies suppression can lead 
to a hazardous situation of infections (Ateş et al., 
2007). Glucocorticoids are frequently associated with 
the described medications above, because prednisone 
exerts potent inhibitory effects on transcription and 
action of cytokines (IL-1β, IL-2, IL-3, IL-6, TNF-α, 
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interferon-γ, T helper type 1 (Th1), and granulocyte 
macrophage colony-stimulating factor), which act 
in the pathogenesis of RA (Ryu et al., 2011), but 
little effect was observed in the immunoglobulin 
synthesis. Boumpas et al. (1993) report that unlike 
T cells, B lymphocytes are relatively resistant to 
the immunosuppressive effects of glucocorticoids. 
Consequently, low dose glucocorticoids are not 
expected to affect immunoglobulin levels or synthesis 
of antibodies in the serum.
In the normal group, the used medications are 
those associated with aging, contraceptives drugs, and 
hormone replacement. Hypertension is a fairly common 
disorder and its prevalence is primarily determined 
by age and ethnicity (Elliott, 2006). Lind et al. (1994) 
found that the long-term use of antihypertensive drugs 
does not affect serum lipid levels. Nevertheless, a 
detailed study of such intakes was not done, because 
just a qualitative survey was applied.
Finally, the PLS method may indicate that the 
rheumatic group had higher elevation in serum levels 
of IgM and/or albumin compared to the normal group. 
These results are also supported by other authors, which 
showed the potential of PLS model associated with 
infrared spectroscopy, helping determine concentrations 
of HSA (human serum albumin) and gammaglobulin 
(Kasemsumran et al., 2003; Perez-Guaita et al., 2013).
Our work supports other similar studies that have 
endeavored to demonstrate that FTIR spectroscopy by 
PLS method may be of interest as a diagnostic tool, 
determining not only biomolecules such as proteins, 
lipids, and gammaglobulins, but also helping to identify 
changes in molecular composition and structure of 
chemical entities. Moreover, the clinical analysis of 
biomarkers showed that even after long-term drug 
therapy, the ACPA is the most specific and sensitive 
to monitor the progress of RA. Finally, the influence 
of medication and eating on both spectral analyzes 
was discussed. In addition to the possible influence 
of risk factors such as smoking, the increased levels 
of ACPA in rheumatic individuals stand out.
Acknowledgements
The authors would like to thank all voluntaries 
and the financial support given by CNPQ (Project 
301022/2012-7) and CAPES for the master fellowship. 
The authors also thank Alene Alder-Rangel for 
reviewing the English.
References
Alarcón GS, Schrohenloher RE, Bartolucci AA, Ward JR, 
Williams HJ, Koopman WJ. Supression of rheumatoid factor 
production by methotrexate in patients with rheumatoid 
arthritis. Evidence for differential influences of therapy and 
clinical status on IgM and IgA rheumatoid factor expression. 
Arthritis and Rheumatism. 1990; 33(8):1156-61. http://
dx.doi.org/10.1002/art.1780330816
Aletaha D, Neogi T, Silman AJ, Funovit SJ, Felson DT, 
Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, 
Cohen MD, Combe B, Costenbader KH, Dougados M, 
Emery P, Ferraccioli G, Hazes JMWH, Hobbs K, Huizinga 
TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, 
Ménard HA, Moreland LW, Naden LR, Pincus T, Smolen 
JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch 
KS, Vencovsky J, Wolfe F, Hawker G. Rheumatoid arthritis 
classification criteria. Arthritis & Rheumatism. 2010; 
62(9):2569-81. http://dx.doi.org/10.1002/art.27584
Ahmed MM, Obaid Al-Ruhaimi KA, Mohammed SH. 
Evaluation of the rheumatoid factors of the IgG, IgM and 
IgA isotypes as prognostic parameters for rheumatoid 
arthritis among Iraqi patients. Indian Journal of Pathology 
& Microbiology. 2010; 53(3):433-8. http://dx.doi.
org/10.4103/0377-4929.68265
Alsalahy MM, Nasser HS, Hashem MM, Elsayed SM. 
Effect of tobacco smoking on tissue protein citrullination 
and disease progression in patients with rheumatoid arthritis. 
Saudi Pharmaceutical Journal. 2010; 18(2):75-80. http://
dx.doi.org/10.1016/j.jsps.2010.02.002
Andriolo A, Martins AR, Ballarati CAF, Barbosa IV, Mendes 
MA, Melo MR, Sumita NM, Romano P, Trindade PA. 
Recomendações da Sociedade Brasileira de Patologia Clínica 
/ Medicina Laboratorial para coleta de sangue venoso. 2th ed. 
São Paulo: Manole Ltda; 2009. p. 16-85. Available from: 
http://www.sbpc.org.br/upload/conteudo/320090814145042.
pdf.
Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke 
on immunity, inflammation and autoimmunity. Journal 
of Autoimmunity. 2010; 34(3):J258-65. http://dx.doi.
org/10.1016/j.jaut.2009.12.003
Ateş A, Karaaslan Y, Aksaray S. Predictive value of antibodies 
to cyclic citrullinated peptide in patients with early arthritis. 
Clinical Rheumatology. 2007; 26(4):499-504. http://dx.doi.
org/10.1007/s10067-006-0309-z
Atzeni F, Sarzi-Puttini P, Dell’Acqua D, De Portu S, Cecchini 
G, Cruini C, Carrabba M, Meroni PL. Adalimumab clinical 
efficacy is associated with rheumatoid factor and anti-cyclic 
citrullinated peptide antibody titer reduction:one-year 
prospective study. Arthritis Research & Therapy. 2006; 
8(1):1-8. http://dx.doi.org/10.1186/ar1851
Bathon JM, Martin RW, Fleischmann RM, Tesser JR, 
Schiff MH, Keystone EC, Genovese MC, Wasko MC, 
Moreland LW, Weaver AL, Markenson J, Finck BK. A 
comparison of etanercepte and methotrexate in patients 
with early rheumatoid arthritis. New England Journal of 
Medicine. 2000; 343(22):1586-93. http://dx.doi.org/10.1056/
NEJM200011303432201
Benhamou MAM. Reconditioning in patients with 
rheumatoid arthritis. Annales de Réadaptation et de Médecine 
Physique. 2007; 50(6):382-5. http://dx.doi.org/10.1016/j.
annrmp.2007.03.023
Rev. Bras. Eng. Bioméd., v. 30, n.1, p. 54-63, mar. 2014
Braz. J. Biom. Eng., 30(1), 54-63, Mar. 201460
Study of advanced rheumatoid arthritis
Bértolo MB, Brenol CV, Schainberg CG, Neubarth F, Lima 
FAC, Laurindo IM, Silveira IG, Pereira IA, Loures MAR, 
Azevedo MN, Freitas MVC, Neto MSP, Xavier RM, Giorgi 
RDN, Kowalski SC, Anti SMA. Atualização do consenso 
brasileiro no diagnóstico e tratamento da artrite reumatóide. 
Revista Brasileira de Reumatologia. 2007; 47(3):151-9.
Birch JT, Bhattacharya S. Emerging trends in diagnosis and 
treatment of rheumatoid arthritis. Primary Care: Clinics 
in Office Practice. 2010; 37(4):779-92. http://dx.doi.
org/10.1016/j.pop.2010.07.001
Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. 
Glucocorticoid therapy for immune-mediated diseases: Basic 
and clinical correlates moderator. Annals of Internal Medicine. 
1993; 119(12):1198-208. http://dx.doi.org/10.7326/0003-
4819-119-12-199312150-00007
Cai B, Wang L, Liu J, Feng W. Performance evaluation 
of Elecsys analysis system for anti-cyclic citrullinated 
peptide detection in comparison with commercially 
available ELISA assays in rheumatoid arthritis diagnosis. 
Clinical Biochemistry. 2011; 44(12):989-93. http://dx.doi.
org/10.1016/j.clinbiochem.2011.05.021
Carvalho CS, Martin AA, Santo AME, Andrade LEC, 
Pinheiro MM, Cardoso MAG, Raniero L. A rheumatoid 
arthritis study using raman spectroscopy. Theoretical 
Chemistry Accounts. 2011; 130(4-6):1211-20. http://dx.doi.
org/10.1007/s00214-011-0905-0
Centers for Disease Control – CDC, Prevention National 
Center for Chronic Disease Prevention and Health Promotion. 
Division of Adult and Community Health. Arthritis 
meeting the challenge. At a glance 2011 [internet]. 2012 
Oct [cited 2013 Oct 30]. Available from: http://www.cdc.
gov/chronicdisease/resources/publications/aag/pdf/2011/
Arthritis-AAG-2011-508.pdf.
Cheng Z. Interaction of ergosterol with bovine serum 
albumin and human serum albumin by spectroscopy analysis. 
Molecular Biology Reports. 2012; 39(10):9493-508. http://
dx.doi.org/10.1007/s11033-012-1814-6
Cheng YJ, Hootman JM, Murphy LB, Langmaid GA, 
Helmick CG. Prevalence of doctor-diagnosed arthritis 
and arthritis-attributable activity limitation - United States 
2007-2009. Morbidity and Mortality Weekly Report. 2010; 
59(39):1261-5.
Cordonnier C, Meyer O, Palazzo E, De Bandt M, Elias A, 
Nicaise P, HaÏm T, Kahn MF, Chatellier G. Diagnostic value 
of anti-ra33 antibody, antikeratin antibody, antiperinuclear 
factor and antinuclear antibody in early rheumatoid arthritis: 
comparison with rheumatoid factor. British Journal of 
Rheumatology. 1996; 35(7):620-4. http://dx.doi.org/10.1093/
rheumatology/35.7.620
Déléris G, Petibois C. Applications of FT-IR spectrometry 
to plasma contents analysis and monitoring. Vibrational 
Spectroscopy. 2003; 32(1):129-36. http://dx.doi.org/10.1016/
S0924-2031(03)00053-5
Desai SP, Januzzi JL, Pande AN, Pomerantsev EV, Resnic 
FS, Fossel A, Chibnik LB, Solomon DH. Comparison of 
symptoms, treatment, and outcomes of coronary artery 
disease among rheumatoid arthritis and matched subjects 
undergoing percutaneous coronary intervention. Seminars 
in Arthritis and Rheumatism. 2010; 40(3):215-21. http://
dx.doi.org/10.1016/j.semarthrit.2010.04.002
Duquerroy S, Stura EA, Bressanelli S, Fabiane SM, Vaney 
MC, Beale D, Hamon M, Casali P, Rey FA, Sutton BJ, 
Taussig MJ. Crystal structure of a human autoimmune 
complex between IgM rheumatoid factor RF61 and IgG1 Fc 
reveals a novel epitope and evidence for affinity maturation. 
Journal of Molecular Biology. 2007; 368(5):1321-31. http://
dx.doi.org/10.1016/j.jmb.2007.02.085
Ebringer A, Rashid T, Wilson C. Rheumatoid arthritis, 
proteus, anti-CCP anibodies and Karl Popper. Autoimmunity 
Reviews. 2010; 9(4):216-23. http://dx.doi.org/10.1016/j.
autrev.2009.10.006
Elefant E, Cournot MP, Beghin D, Vauzelle C. Rheumatology 
drugs and pregnancy. Joint Bone Spine. 2010; 77(6):506-10. 
http://dx.doi.org/10.1016/j.jbspin.2010.09.007
Elliott H. Epidemiology, aetiology and prognosis of 
hypertension. Medicine. 2006; 34(8):286-9. http://dx.doi.
org/10.1053/j.mpmed.2006.06.002
Filipovic I, Walker D, Forster F, Curry AS. Quantifying 
the economic burden of productivity loss in rheumatoid 
arthritis. Rheumatology (Oxford). 2011; 50(6):1083-90. 
http://dx.doi.org/10.1093/rheumatology/keq399
Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy 
S, Sergent JS. Kelley’s textbook of rheumatology. 5th ed. 
Philadelphia: Saunders Elsevier; 2009. p. 755-62.
Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. 
Reduction in long-term disability in patients with rheumatoid 
arthritis by disease-modifying antirheumatic drug-based 
treatment strategies. Arthritis and Rheumatism. 1996; 
39(4):616-22. http://dx.doi.org/10.1002/art.1780390412
Gelamo EL, Tabak M. Spectroscopic studies on the interaction 
of bovine (BSA) and human (HSA) serum albumins with 
ionic surfactants. Spectrochimica Acta Part A Molecular 
Biomolecular Spectroscopy. 2000; 56(11):2255-71. http://
dx.doi.org/10.1016/S1386-1425(00)00313-9
Goeldner I, Skare TL, Reason ITM, Nisihara RM, Silva 
MB, Utiyama SRR. Association of anticyclic citrullinated 
peptide antibodies with extra-articular manifestations, gender, 
and tabagism in rheumatoid arthritis patients from southern 
Brazil. Clinical Rheumatology. 2011; 30(7):975-80. http://
dx.doi.org/10.1007/s10067-011-1711-8
Hambright D, Henderson RA, Cook C, Worrel T, Moorman 
CT, Bolognesi MP. A comparison of perioperative outcomes 
in patients with and without rheumatoid arthritis after 
receiving a total shoulder replacement arthroplasty. Journal 
of Shoulder and Elbow Surgery. 2011; 20(1):77-85. http://
dx.doi.org/10.1016/j.jse.2010.03.005
Haro I, Gómara MJ, Pérez ML, Viñas O, Ercilla G, Gómez-
Puerta JA, Sanmartí R. Antibodies against ß-fibrin synthetic 
peptides: A study of their association with the immunogenetic 
background and disease course of rheumatoid arthritis 
patients. European Journal of Medicinal Chemistry. 
2011; 46(4):1095-102. http://dx.doi.org/doi: 10.1016/j.
ejmech.2011.01.024
Rev. Bras. Eng. Bioméd., v. 30, n. 1, p. 54-63, mar. 2014
Braz. J. Biom. Eng., 30(1), 54-63, Mar. 2014 61
Carvalho CS, Andrade LEC, Keusseyan SP, Rangel JL, Ferreira-Strixino J, AA Martin, Raniero LJ
Hsin-Hua C, Der-Yuan C, Tsu-Yi H, Guo-Dung H, Howard 
HCL, Chia-Wei H, Joung-Liang L. Predicting the progression 
of palindromic rheumatism to rheumatoid arthritis: The role 
of ultrasonography and anti-cyclic citrullinated peptide 
antibodies. Journal of Medical Ultrasound. 2010; 18(1):17-
26. http://dx.doi.org/10.1016/S0929-6441(10)60003-3
Hoet RM, Voorsmit RA, Van Venrooij WJ. The perinuclear 
factor, a rheumatoid arthritis-specific autoantigen, is not 
present keratohyalin granules of cultured buccal mucosa 
cell. Clinical and Experimental Immunology. 1991; 84(1):59-
65. http://dx.doi.org/10.1111/j.1365-2249.1991.tb08124.x
Karlson EW, Deane K. Environmental and gene-environment 
interactions and risk of rheumatoid arthritis. Rheumatic 
Diseases Clinics of North America. 2012; 38(2):405-26. 
http://dx.doi.org/10.1016/j.rdc.2012.04.002
Kasemsumran S, Du YP, Murayama K, Huehne M, Ozaki 
Y. Simultaneous determination of human serum albumin, 
γ-globulin, and glucose in a phosphate buffer solution by 
near-infrared spectroscopy with moving window partial 
least-squares regression. Analyst. 2003; 128(12):1471-7. 
http://dx.doi.org/10.1039/b307294k
Klaasen R, Cantaert T, Wijbrandts CA, Teitsma C, Gerlag 
DM, Out TA, de Nooijer MJ, Baeten D, Tak PP. The value of 
rheumatoid factor and anti-citrullinated protein antibodies as 
predictors of response to infliximab in rheumatoid arthritis: an 
exploratory study. Rheumatology (Oxford). 2011; 50(8):1487-
93. http://dx.doi.org/10.1093/rheumatology/ker010
Külkamp W, Dario AB, Gevaerd MS, Domenech SC. Artrite 
reumatóide e exercício físico: resgate histórico e cenário 
atual. Revista Brasileira de Atividade Física & Saúde. 
2009; 14(1):55-64.
Liao J, Ip WS, Cheung KY, Wan WM, Cautherley GW, Cai 
X, Lin X, Renneberg R, Chan CP. Diagnostic utility of an 
anti-CCP point-of-care immunotest in Chinese patients with 
rheumatoid arthritis. Clinica Chimica Acta. 2011; 412(9-
10):778-81. http://dx.doi.org/10.1016/j.cca.2011.01.013
Lind L, Pollare T, Berne C, Lithell H. Long-term metabolic 
effects of antihypertensive drugs. American Heart Journal. 
1994; 128(6):1177-83. http://dx.doi.org/10.1016/0002-
8703(94)90749-8
Lipsky PE, Van der Heijde DM, St Clair EW, Furst DE, 
Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery 
P, Feldmann M, Harriman GR, Maini RN; Anti-tumor 
necrosis factor trial in rheumatoid arthritis with concomitant 
therapy study group. Infliximab and methotrexate in the 
treatment of rheumatoid arthritis. New England Journal of 
Medicine. 2000; 343(22):1594-602. http://dx.doi.org/10.1056/
NEJM200011303432202
Lutteri L, Malaise M, Chapelle JP. Comparison of second- and 
third-generation anti-cyclic citrullinated peptide antibodies 
assays for detecting rheumatoid arthritis. Clinica Chimica 
Acta. 2007; 386(1-2):76-81. http://dx.doi.org/10.1016/j.
cca.2007.08.002
Malaviya AN, Collings JB, Makol A, Kaushik P. Effect 
of baseline rheumatoid factor (RF) levels on DAS28-
response to standard DMARD-combination treatment in 
patients with rheumatoid arthritis (RA). Indian Journal of 
Rheumatology. 2009; 4(2):51-5. http://dx.doi.org/10.1016/
S0973-3698(10)60174-4
Martínez EO, Ramírez DFH, Núñez-Álvarez CA, Cabiedes J. 
Proteínas citrulinadas en artritis reumatoide. Reumatología. 
Clínica. 2011; 7(1):68-71. http://dx.doi.org/10.1016/j.
reuma.2009.09.010
Mouterde G, Baillet A, Gaujoux-Viala C, Cantagrel A, 
Wendling D, Le Löet X, Schaeverbeke T. Optimizing 
methotrexate therapy in rheumatoid arthritis: A systematic 
literature review. Joint Bone Spine. 2011; 78(6):587-92. 
http://dx.doi.org/10.1016/j.jbspin.2011.01.01
Muñoz de la Peña A, Merás ID, Jiménez GA, Goicoechea 
HC. Evaluation of unfolded-partial least squares coupled to 
residual trilinearization for four-way calibration of folic acid 
and methotrexate in human serum samples. Talanta. 2007; 
72(4):1261-8. http://dx.doi.org/10.1016/j.talanta.2007.01.018
Narváez J, Sirvent E, Narváez JA, Bas J, Gómez-Vaquero 
C, Reina D, Nolla JM, Valverde J. Usefulness of magnetic 
resonance imaging of the hand versus anticyclic citrullinated 
peptide antibody testing to confirm the diagnosis of clinically 
suspected early rheumatoid arthritis in the absence of 
rheumatoid factor and radiographic erosions. Seminars in 
Arthritis and Rheumatism. 2008; 38(2):101-9. http://dx.doi.
org/10.1016/j.semarthrit.2007.10.012
Naumann D. Vibrational spectroscopy in microbiology and 
medical diagnostics. In: Lasch P, Kneipp J, editors. Biomedical 
Vibrational Spectroscopy. John Wiley & Sons: Canadá; 
2008. p. 385. http://dx.doi.org/10.1002/9780470283172.ch1
Nienhius RLF, Mandema E, Smids C. New serum factor in 
patients with rheumatoid arthritis: the antiperinuclear factor. 
Annals of the Rheumatic Diseases. 1964; 23(4):302-5. http://
dx.doi.org/10.1136/ard.23.4.302
Niewold TB, Harrison MJ, Paget SA. Anti-CCP antibody 
testing as a diagnostic and prognostic tool in rheumatoid 
arthritis. Quarterly Journal of Medicine. 2007; 100:193-201. 
http://dx.doi.org/10.1093/qjmed/hcm015
Raniero L, Canevari RA, Ramalho LNZ, Ramalho FS, Santos 
EAP, Bitar RA, Jalkanen KJ, Martinho HS, Martin AA. In 
and ex vivo breast disease study by raman spectroscopy. 
Theoretical Chemistry Accounts. 2011; 130(4-6):1239-47. 
http://dx.doi.org/10.1007/s00214-011-1027-4
Ruiz-Esquide V, Sanmartí R. Tobacco and other environmental 
risk factors in rheumatoid arthritis. Reumatología 
Clinica. 2012; 8(6):342-50. http://dx.doi.org/10.1016/j.
reuma.2012.02.011
Ryu HJ, Takeuchi F, Kuwata S, Kim YJ, Lee EY, Lee EB, 
Song YW. The diagnostic utilities of anti-agalactosyl IgG 
antibodies, anti-cyclic citrullinated peptide antibodies, and 
rheumatoid factors in rheumatoid arthritis. Rheumatolology 
International. 2011; 31(3):315-9. http://dx.doi.org/10.1007/
s00296-009-1260-5
Okamoto S, Adachi M, Chujo S, Yamada K, Akita K, Itoh S, 
Takii T, Hayakawa K, Onozaki K. Etiological role of cigarette 
smoking in rheumatoid arthritis: Nasal exposure to cigarette 
smoke condensate extracts augments the development 
of collagen-induced arthritis in mice. Biochemical and 
Rev. Bras. Eng. Bioméd., v. 30, n.1, p. 54-63, mar. 2014
Braz. J. Biom. Eng., 30(1), 54-63, Mar. 201462
Study of advanced rheumatoid arthritis
Biophysical Research Communications. 2011; 404(4):1088-
92. http://dx.doi.org/10.1016/j.bbrc.2010.12.118
Østergaard M, Pederse SJ, Døhn UM. Imaging in rheumatoid 
arthritis-status and recent advances for magnetic resonance 
imaging, ultrasonography, computed tomography and 
conventional radiograph. Best Practice & Research 
Clinical Rheumatology. 2008; 22(6):1019-44. http://dx.doi.
org/10.1016/j.berh.2008.09.014
Otterness IG. The value of C-Reactive protein measurement in 
Rheumatoid Arthritis. Seminars in. Arthritis and Rheumatism. 
1994; 24(2):91-104. http://dx.doi.org/10.1016/S0049-
0172(05)80003-4
Petibois C, Cazorla G, Cassaigne A, Déléris G. Plasma 
protein contents determined by Fourier-Transform Infrared 
Spectrometry. Clinical Chemistry. 2001; 47(4):730-8.
Petibois C, Rigalleau V, Melin AN, Perromat A, Cazorla 
G, Gin H, Deléris G. Determination of glucose in dried 
serum samples by Fourier-Transform Infrared spectroscopy. 
Clinical Chemistry. 1999; 45(9):1530-5.
Perez-Guaita D, Ventura-Gayete J, Pérez-Rambla C, Sancho-
Andreu M, Garrigues S, De la Guardia M. Evaluation of 
infrared spectroscopy as a screening tool for serum analysis. 
Impact of the nature of samples included in the calibration 
set. Microchemical Journal. 2013; 106:202-11. http://dx.doi.
org/10.1016/j.microc.2012.06.016
Plasqui G. The role of physical activity in rheumatoid 
arthritis. Physiology and Behavior. 2008; 94(2):270-5. 
http://dx.doi.org/10.1016/j.physbeh.2007.12.012
Romic Z, Unic A, Derek L, Zivkovic M, Marijancevic 
D, Kes P, Pehar M. Anti-citrullinated protein antibody 
and rheumatoid factor in patients with end-stage renal 
disease. Clinical Chemistry and Laboratory Medicine. 2009; 
47(8):959-62. http://dx.doi.org/10.1515/CCLM.2009.217
Sankari G, Krishnamoorthy E, Jayakumaran S, Gunasekaran 
S, Priya VV, Subramaniam S, Subramaniam S, Mohan 
SK. Analysis of serum immunoglobulins using Fourier 
Transform Infrared spectral measurements. Biology and 
Medicine. 2010; 2(3):42-8.
Santos WS, Silva NP, Atra E, Andrade LEC. Diagnostic 
value of antiperinuclear factor and anti-stratum corneum 
antibody in rheumatoid arthritis. Revista Brasileira de 
Reumatologia. 1997; 37(5): 251-9.
Staib A, Dolenko B, Fink DJ, Früh J, Nikulin AE, Otto M, 
Pessin-Minsley MS, Quarder O, Somorjai R, Thienel U, 
Werner G, Petrich W. Disease pattern recognition testing for 
rheumatoid arthritis using infrared spectra of human serum. 
Clinica Chimica Acta. 2001; 308(1-2):79-89.
Swart A, Burlingame RW, Gürtler I, Mahler M. Third 
generation anti-citrullinated peptide antibody assay is a 
sensitive marker in rheumatoid factor negative rheumatoid 
arthritis. Clinica Chimica Acta. 2012; 414:266-72. http://
dx.doi.org/10.1016/j.cca.2012.09.015
Universidade Estadual de Campinas - UNICAMP. Tabela 
brasileira de composição de alimentos - TACO [internet]. 
Campinas: UNICAMP/NEPA; 2011. [cited 2011 Sep 9]. 
Available from: http://www.unicamp.br/nepa/taco/contar/
taco_4_edicao_ampliada_e_revisada.pdf?arquivo=taco_4_
versao_ampliada_e_revisada.pdf.
Vallbracht I, Helmke K. Additional diagnostic and clinical 
value of anti-cyclic citrullinated peptide antibodies compared 
with rheumatoid factor isotypes in rheumatoid arthritis. 
Autoimmunity Reviews. 2005; 4(6):389-94. http://dx.doi.
org/10.1016/j.autrev.2005.02.001
Vander Cruyssen B, Peene I, Cantaert T, Hoffman IEA, 
De Rycke L, Veys EM, De Keyse F. Anti-citrullinated 
protein/peptide antibodies (ACPA) in rheumatoid arthritis: 
specificity and relation with rheumatoid factor. Autoimmunity 
Reviews. 2005; 4(7):468-74. http://dx.doi.org/10.1016/j.
autrev.2005.04.018
Van der Linden MP, Batstra MR, Bakker-Jonges LE; 
Foundation for Quality Medical Laboratory Diagnostics, 
Detert J, Bastian H, Scherer HU, Toes RE, Burmester GR, 
Mjaavatten MD, Kvien TK, Huizinga TW, Van der Helm-
van Mil AH. Toward a data-driven evaluation of the 2010 
American College of Rheumatology/European League 
against rheumatism criteria for rheumatoid arthritis: Is it 
sensible to look at levels of rheumatoid factor? Arthritis and 
Rheumatism. 2011; 63(5):1190-9. http://dx.doi.org/10.1002/
art.30200
Van Venrooij WJ, Zendman AJW, Pruijn GJM. Autoantibodies 
to citrullinated antigens in (early) rheumatoid arthritis. 
Autoimmunity Reviews. 2006; 6:37-1. http://dx.doi.
org/10.1016/j.autrev.2006.03.008
Zavala-Cerna MG, Nava A, García-Castañeda E, Durán-
González J, Arias-Merino MJ, Salazar-Páramo M. Serum 
IgG activity against cyclic citrullinated peptide in patients 
evaluated for rheumatoid factor correlates with the IgM 
isotype. Rheumatology International. 2008; 28(9):851-7. 
http://dx.doi.org/10.1007/s00296-008-0535-6
Waljee JF, Chung KC. Outcomes research in rheumatoid 
arthritis. Hand Clinics. 2011; 27(1):115-26. http://dx.doi.
org/10.1016/j.hcl.2010.10.005.
Authors 
Carolina da Silva Carvalho, João Lucas Rangel, Juliana Ferreira-Strixino, Airton Abrahão Martin, Leandro Raniero* 
Instituto de Pesquisa e Desenvolvimento – IP&D, Universidade do Vale do Paraíba – UniVap, Av. Shishima Hifumi, 2911, 
Urbanova, CEP 12244-000, São José dos Campos, SP, Brazil
Luiz Eduardo Coelho Andrade, Silene Peres Keusseyan 
Divisão de Reumatologia, Departamento de Medicina, Universidade Federal de São Paulo – UniFesp, São Paulo, SP, Brazil
Rev. Bras. Eng. Bioméd., v. 30, n. 1, p. 54-63, mar. 2014
Braz. J. Biom. Eng., 30(1), 54-63, Mar. 2014 63
